Gsk (GSK) EBITDA Margin (2009 - 2026)
Gsk (GSK) posted EBITDA Margin of 9156.15% for the quarter ended Mar 31, 2026.
Powered by 
Analysis
Gsk (GSK) EBITDA Margin (2009 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Gsk's EBITDA Margin came in at 35.85%, up 13.52 percentage points from the prior year.
- Annual EBITDA Margin shows a five-year change of +15.28 percentage points (years ended Dec 2020 to Dec 2025).
- In prior years, Gsk's EBITDA Margin was 22.33% in the year ended Dec 31, 2024 (-9.30 pp), 31.63% in the year ended Dec 31, 2023 (+5.14 pp), 26.49% in the year ended Dec 31, 2022 (+4.44 pp) and 22.05% in the year ended Dec 31, 2021 (+1.48 pp).
- The figure for the quarter ended Mar 31, 2026 stands as the lowest quarterly EBITDA Margin since the quarter ended Dec 31, 2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | 35.10% |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | 39.16% |
| 10 | Gsk | 100.33 Bn | 81.91 Bn | 8.24 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 36.13% |
| Mar 31, 2025 | 40.43% |
| Dec 31, 2024 | 19.00% |
| Mar 31, 2024 | 27.69% |
| Dec 31, 2023 | 21.75% |
| Mar 31, 2023 | 39.16% |
| Dec 31, 2022 | 25.42% |
| Mar 31, 2022 | 37.71% |
| Dec 31, 2021 | 13.06% |
| Mar 31, 2021 | 30.48% |
| Mar 31, 2020 | 24.29% |
| Dec 31, 2019 | 27.26% |
| Sep 30, 2019 | 28.34% |
| Mar 31, 2019 | 34.08% |
| Dec 31, 2018 | 26.20% |
| Mar 31, 2018 | 23.79% |
| Dec 31, 2017 | 19.63% |
| Mar 31, 2017 | 27.68% |
| Dec 31, 2016 | 8.88% |
| Dec 31, 2012 | 128.57% |
API Access
Gsk EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();